The Technical Analyst
Artelo Biosciences, Inc. [ARTLW]
Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Artelo Biosciences, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0117
/ 22 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4.20 mill |
| EPS: | -1.429 |
| P/E: | -0.0100 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 358.74 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2024-04-22 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0100 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.0100 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$2.41 (20 490.66%) $2.40 |
| Date: 2024-04-24 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0017 - 0.0217 ( +/- 85.47%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-05 | Gorgas Gregory D. | Buy | 92 000 | Stock Option (right to buy) |
| 2023-08-04 | Matsui Connie | Buy | 1 083 | Stock Option (right to buy) |
| 2023-08-04 | Blayney Douglas | Buy | 1 083 | Stock Option (right to buy) |
| 2023-08-04 | Reyes Gregory | Buy | 1 083 | Stock Option (right to buy) |
| 2023-08-04 | Emanuele Robert Martin | Buy | 1 083 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 100.00 |
| Last 64 transactions |
| Buy: 4 184 534 | Sell: 89 374 |
Forecast: